Abstract
The overall aim of the project is to test the feasibility and safety of allogeneic adipose-derived stromal cell (CSCC_ASC) investigational medicinal product to improve myocardial function in patients with non-ischemic dilated cardiomyopathies (NIDCM) and heart failure.
The Heart Centre, Rigshospitalet University Hospital Copenhagen, Copenhagen, Denmark
ClinicalTrials.gov Identifier: NCT03797092
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Weiss, J.N. (2022). Stem Cell Therapy in Non-ischemic, Non-treatable Dilated Cardiomyopathies II: A Pilot Study. In: Stem Cell Surgery Trials in Heart Failure and Diabetes. Springer, Cham. https://doi.org/10.1007/978-3-030-78010-4_13
Download citation
DOI: https://doi.org/10.1007/978-3-030-78010-4_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-78009-8
Online ISBN: 978-3-030-78010-4
eBook Packages: MedicineMedicine (R0)